ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
澳股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
新冠治疗股
909.216
-4.061
-0.44%
涨家数:
10
跌家数:
5
平家数:
17
市盈率:
- -
高:
915.545
开:
915.545
低:
905.057
收:
913.277
成交量:
1,586.23万
成交额:
1.42亿
市值:
2,363.53亿
流通市值:
1,831.21亿
数据加载中...
总览
新闻
Mesoblast将于下月与FDA会谈讨论Rexlemestrocel-L和阿片类药物戒断
投资观察
·
11/05
Mesoblast将于下月与FDA会面讨论Rexlemestrocel-L和药物戒断
美股速递
·
11/05
CSL LIMITED - CSL Seqirus与疫苗工业公司与卫生部签署重要谅解备忘录
美股速递
·
10/30
Coles Group Ltd - 第二季度初期,超市销售收入增长保持在与第一季度相似的水平
美股速递
·
10/30
葛兰素史克抗癌、抗艾滋病药物销售额提升,2025 年前景看好,股价大涨
路透中文
·
10/29
美国市场动荡不安,澳大利亚 CSL 公司推迟分拆疫苗部门
路透中文
·
10/28
CSL Ltd - 先前提出的拆分时间推进将无法充分体现Seqirus的价值潜力
美股速递
·
10/28
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK7501/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"新冠治疗股","latestPrice":909.2155,"timestamp":1762745474883,"preClose":913.27673,"halted":0,"volume":15862269,"delay":0,"changeRate":-0.004447,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-4.061218,"latestTime":"11-10 14:31:15 AEDT","open":915.5452,"high":915.5452,"low":905.0574,"amount":141512173,"amplitude":0.011484,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1762750800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762729200000,1762750800000]],"turnoverRate":0.001103,"increases":10,"decrements":6,"flats":16,"marketCap":236353454736.25,"floatMarketCap":183120960845.58594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":915.5452,"amplitude":0.011484,"preClose":913.27673,"low":905.0574,"latestPrice":909.2155,"volume":15862269,"delay":0,"open":915.5452,"prevYearClose":1117.913,"prevWeekClose":913.277,"prevMonthClose":914.468,"prevQuarterClose":950.171,"fiveDayClose":902.484,"twentyDayClose":972.908,"sixtyDayClose":1133.772,"secType":"PLATE","market":"AU","turnoverRate":0.001103,"marketCap":236353454736.25,"floatMarketCap":183120960845.58594,"timestamp":1762745474883,"nameCN":"新冠治疗股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":10,"down":5,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1116191251","title":"Mesoblast将于下月与FDA会谈讨论Rexlemestrocel-L和阿片类药物戒断","url":"https://stock-news.laohu8.com/highlight/detail?id=1116191251","media":"投资观察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116191251?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 09:45","pubTimestamp":1762307124,"startTime":"0","endTime":"0","summary":"11月5日(路透社) - Mesoblast Ltd:*MESOBLAST将于下月与FDA会面,讨论Rexlemestrocel-L和阿片类药物戒断* 进一步公司报道:MSB.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"gpt_icon":0},{"id":"1199521939","title":"Mesoblast将于下月与FDA会面讨论Rexlemestrocel-L和药物戒断","url":"https://stock-news.laohu8.com/highlight/detail?id=1199521939","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199521939?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 06:59","pubTimestamp":1762297168,"startTime":"0","endTime":"0","summary":"Mesoblast将于下月与FDA会面,讨论Rexlemestrocel-L和药物戒断的相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MESO","BK7501","MSB.AU","BK7067","BK4139"],"gpt_icon":0},{"id":"1185215746","title":"CSL LIMITED - CSL Seqirus与疫苗工业公司与卫生部签署重要谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1185215746","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185215746?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 13:55","pubTimestamp":1761803711,"startTime":"0","endTime":"0","summary":"CSL LIMITED - CSL Seqirus与疫苗工业公司与卫生部签署重要谅解备忘录","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"gpt_icon":0},{"id":"1193087172","title":"Coles Group Ltd - 第二季度初期,超市销售收入增长保持在与第一季度相似的水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1193087172","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193087172?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 05:29","pubTimestamp":1761773349,"startTime":"0","endTime":"0","summary":"Coles Group Ltd - 第二季度初期,超市销售收入增长保持在与第一季度相似的水平","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7082","COL.AU","BK7040"],"gpt_icon":0},{"id":"2579204689","title":"葛兰素史克抗癌、抗艾滋病药物销售额提升,2025 年前景看好,股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2579204689","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579204689?lang=zh_cn&edition=fundamental","pubTime":"2025-10-29 17:24","pubTimestamp":1761729849,"startTime":"0","endTime":"0","summary":"更新版 1-更新 2-葛兰素史克抗癌、抗艾滋病药物销售额提升,2025 年前景看好,股价大涨股价上涨近 4%,达到 2024 年 5 月以来的最高水平 即将离任的首席执行官沃姆斯利在本季度表现强劲 非美国市场推动疫苗销售增长添加领涨股票、图表和美国疫苗销售详情Bhanvi Satija/Yadarisa Shabong. 美国疫苗销售压力 葛兰素史克表示,在截至9月30日的季度里,公司疫苗销售总额达到26.8亿英镑,高于分析师预测的25.5亿英镑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4T3WA0XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0225771236.USD","LU1670756490.USD","LU1098665638.USD","GSK.UK","BK5011","LU0971552673.USD","BK7511","IE00BWDBJ516.SGD","LU1035777561.USD","LU1481599808.USD","LU0225284248.USD","LU1481600234.SGD","LU1400636491.USD","BK7501","LU1309081286.SGD","BK7067","LU1487256676.USD","IE00BQJZX424.USD","LU0321505439.SGD","LU1400636574.HKD","LU0971552830.HKD","LU1015430645.USD","LU0211331839.USD","LU1064927863.SGD","LU0109981661.USD","LU0575583348.USD","LU1302929846.USD","CSL.AU","LU0545562505.USD","LU1228905037.USD","LU0289739699.SGD","LU0306806265.USD","LU0203347892.USD","LU0306807586.USD","LU1400636657.SGD","LU0321505868.SGD","LU0985481810.HKD","IE0034235071.USD","LU1046248800.SGD","LU1202635105.USD","LU0161305163.EUR","BK7508","LU1645745479.HKD","LU1228905540.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2578740406","title":"美国市场动荡不安,澳大利亚 CSL 公司推迟分拆疫苗部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2578740406","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578740406?lang=zh_cn&edition=fundamental","pubTime":"2025-10-28 06:23","pubTimestamp":1761603803,"startTime":"0","endTime":"0","summary":"美国市场动荡不安,澳大利亚 CSL 公司推迟分拆疫苗部门路透10月27日 - 澳大利亚生物技术公司CSL CSL.AX周二表示,由于美国流感疫苗市场波动加剧,该公司不再以在2026财年完成疫苗部门的分拆为目标。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL4S3W81OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"gpt_icon":0},{"id":"1194146757","title":"CSL Ltd - 先前提出的拆分时间推进将无法充分体现Seqirus的价值潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194146757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194146757?lang=zh_cn&edition=fundamental","pubTime":"2025-10-28 06:12","pubTimestamp":1761603128,"startTime":"0","endTime":"0","summary":"CSL Ltd - 先前提出的拆分时间推进将无法充分体现Seqirus的价值潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7508","BK7501","BK7067","BK7511"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}